Irmgard Costa

Learn More
4568 Background: 3% to 5% of non-small cell lung cancers demonstrate translocation of the anaplastic lymphoma kinase (ALK) gene. This genetic event is associated with tumor sensitivity to ALK inhibitors. ALK gene translocations, copy number gains or amplification, mutations, and expression, have been not characterized in UC. Our aim was to determine the(More)
  • 1